Back to Authors

Tellingen, Olaf van

0000-0002-1037-6269

Mayo Clinic

The Netherlands Cancer Institute

Citations 1

Comments on: “Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity”
Gooijer, Mark C. de , Sarkaria, Jann N. , Elmquist, William F. , Sarkaria, Jann N , Tellingen, Olaf van

Neuro-Oncology | April 23, 2020 | Volume: 22 | Issue: 9 | Pages: 1404-1405

10.1093/neuonc/noaa112 Get It